Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...

There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...

Tech CEOs are promising increasingly outlandish visions of the 2030s, powered by "superintelligence", but the reality is that ...

Tech leaders are divided on AI's job impact, with some concerned it'll take over jobs and spike unemployment, and others ...

Meanwhile, tech giants like Amazon and Microsoft are slashing their workforce amid massive spending to build and deploy new ...

I t’s a truism that, the more you learn, the more you realize how much you don’t know. That mentality holds in most traditional academic disciplines, where humility is a survival strategy that keeps ...

The thinking behind Thinking Machines Lab, a high-profile but mysterious artificial intelligence startup led by former OpenAI ...

Sir Demis Hassabis said it feels like a recognition that AI is mature enough now to help with scientific discovery. Read more at straitstimes.com. Read more at straitstimes.com.

Google DeepMind CEO, Demis Hassabis, forecasts a bright future with Artificial General Intelligence. He believes AGI will spark a golden age for human ...